Target Validation in Drug Discovery - Dillon - Books - Elsevier Science Publishing Co Inc - 9780123693938 - September 1, 2006
In case cover and title do not match, the title is correct

Dillon
Target Validation in Drug Discovery

Get an email once the item is available
Do you have a profile? Log in

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.

296 pages, Illustrated

Media Books     Hardcover Book   (Book with hard spine and cover)
Released September 1, 2006
ISBN13 9780123693938
Publishers Elsevier Science Publishing Co Inc
Pages 296
Dimensions 184 × 260 × 24 mm   ·   820 g
Editor Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.)
Editor Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.)

More by Dillon

Show all

See all of Dillon ( e.g. Book , CD , LP , Paperback Book and Hardcover Book )